Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | P15 - Poster Session 15

Thursday 04/30/20
12:00 PM - 01:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Neuromuscular and Clinical Neurophysiology (EMG), Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuro Trauma, Critical Care, and Sports Neurology
0.00 credit
Event Timeline
12:00 PM - 01:00 PM Abstract 9-001 - Spinal Cord Area Correlates with Disability and Quality of Life in Progressive MS: A Baseline MRI Analysis from the SPI2 Phase 3 Trial of MD1003 (high dose Pharmaceutical grade Biotin)
Amber M. Alexander
12:00 PM - 01:00 PM Abstract 9-002 - Characterizing Long-Term Disability Progression Outcomes in NARCOMS Registry MS Participants Taking Dimethyl Fumarate
Amber Salter, PhD
12:00 PM - 01:00 PM Abstract 9-003 - Kappa free light chain in multiple sclerosis: higher sensitivity but lower specificity than oligoclonal bands.
Xavier Ayrignac
12:00 PM - 01:00 PM Abstract 9-004 - Using Machine Learning to Extract Expanded Disability Status Scale (EDSS) Scores from Consult Notes
12:00 PM - 01:00 PM Abstract 9-005 - Disability assessment in the Google Maps era: a feasibility study to explore a new clinical opportunity
Gianmarco Abbadessa, MD
12:00 PM - 01:00 PM Abstract 9-006 - A claims-based proxy for the EDSS score in multiple sclerosis using German claims data
Licinio M. Craveiro, MD, PhD
12:00 PM - 01:00 PM Abstract 9-007 - Multiple Sclerosis Patient’s Health Care Utilization Influenced by MS Wellness Shared Medical Appointments – A Single Center Experience
Justin Abbatemarco, MD
12:00 PM - 01:00 PM Abstract 9-008 - Treatment and Comorbidities of Trigeminal Neuralgia in Patients Diagnosed with Multiple Sclerosis at a Large Tertiary Medical Center
Preethy Pankaj, MBBS
12:00 PM - 01:00 PM Abstract 9-009 - Video oculography as a complementary tool to Brain MRI to confirm early demyelinating process in Multiple Sclerosis Subtypes.
Mikael Cohen
12:00 PM - 01:00 PM Abstract 9-010 - Demographic and health related factors associated with use of exercise and mind-body therapies in people with multiple sclerosis
Grace Clark
12:00 PM - 01:00 PM Abstract 9-011 - A cross-sectional exploration of four CSF and plasma biomarkers across headache, multiple sclerosis, and neuromyelitis optica spectrum disorder
Robert H. Gross, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 9-012 - Tailoring B-cells depleting therapy in MS according to memory B-cells monitoring: a pilot study
12:00 PM - 01:00 PM Abstract 9-013 - Comparing HCP and Patient Perceptions of Conversations about Disease Progression in MS
Mitzi J. Williams, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 9-014 - Changes in Oxygen Saturation and the Retinal Nerve Fibre Layer in Patients with Optic Neuritis during a Six-Month Follow-up
Petr Hlustik, MD, PhD
12:00 PM - 01:00 PM Abstract 9-015 - Automated EDSS scoring using a mobile App and Machine learning.
Charisse D. Litchman, MD
12:00 PM - 01:00 PM Abstract 9-016 - Ocrelizumab treatment is not associated with an increase in anti-JCV antibody index
Torge Rempe, MD
12:00 PM - 01:00 PM Abstract 9-017 - Validation of Timed 25-Foot Walk Benchmarks in People with Multiple Sclerosis
Emily S. Riser, MD
12:00 PM - 01:00 PM Abstract 9-018 - Change in Expanded Timed Get-Up-and-Go is Associated with the Expanded Disability Status Scale and Timed 25-Foot Walk in the New York State Multiple Sclerosis Consortium
Bianca Weinstock-Guttman, MD
12:00 PM - 01:00 PM Abstract 9-019 - The Multiple Sclerosis Comorbidity Index as a Tool for EDSS Prediction: Comparison to the Charlson Comorbidity Index and Elixhauser Comorbidity Measure
12:00 PM - 01:00 PM Abstract 9-020 - Prospective Analysis of Cerebrospinal Fluid Protein Levels Reveals Candidate Biomarkers for Disability Outcome in Multiple Sclerosis
Aksel Siva, MD
12:00 PM - 01:00 PM Abstract 9-021 - Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS)
12:00 PM - 01:00 PM Abstract 15-001 - Functioning and Disability in Neurosarcoidosis from the Patient Perspective
Brandon P. Moss, MD
12:00 PM - 01:00 PM Abstract 15-002 - Optical coherence tomography demonstrates occult optic neuropathy in neurosarcoidosis
Ruth Andrea Salazar Camelo, MD
12:00 PM - 01:00 PM Abstract 15-003 - First Case of an Anterior Spinal Artery Stroke in Neurosarcoidosis: A case report and review of literature
Nirav Sanghani, MBBS
12:00 PM - 01:00 PM Abstract 15-004 - Neurosarcoidosis presenting as limbic encephalitis
Ashmanie Mahatoo, MD
12:00 PM - 01:00 PM Abstract 15-005 - Neurosarcoidosis with Radiographic Findings Consistent with CLIPPERS
Ali Y. Mohamud, MD
12:00 PM - 01:00 PM Abstract 15-006 - Cerebral Aspergillosis Masquerading as Progression of Neurosarcoidosis in a Patient with Biopsy Proven Pulmonary Sarcoidosis
William Ueng, MD
12:00 PM - 01:00 PM Abstract 15-007 - Clinical features of isolated optic neuritis due to sarcoidosis: an institutional experience
Sushant Puri, MBBS
12:00 PM - 01:00 PM Abstract 15-008 - Immunoglobulin G4-related hypertrophic pachymeningitis mimicking temporal arteritis: A case report
Jee-young Han, MD
12:00 PM - 01:00 PM Abstract 15-009 - Characteristic Imaging Findings of Susac Syndrome: A Case Report
Arthur D. Mauricio
12:00 PM - 01:00 PM Abstract 15-010 - Granulomatosis with Polyangiitis-Associated Hypertrophic Pachymeningitis as a Neurosarcoidosis Mimic
Joshua Kramer, MD
12:00 PM - 01:00 PM Abstract 15-011 - A Case of Refractory Necrotizing Idiopathic Hypophysitis Presenting as Recurrent Bitemporal Hemianopsia
12:00 PM - 01:00 PM Abstract 15-012 - Amyloid Beta-related Angiitis in the Immunosuppressed: A Case Report
Thomas A. Nelson, MD
12:00 PM - 01:00 PM Abstract 3-001 - An Open-Label, Phase 1b Study of the Neuroactive Steroid GABAA Receptor Positive Allosteric Modulator SAGE-324 in Essential Tremor
Koji Takahashi, PhD
12:00 PM - 01:00 PM Abstract 3-002 - Progression from Mild Cognitive Impairment to Dementia in an Essential Tremor Cohort
Elan D. Louis, MD, MS, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 3-003 - Higher Prevalence of Tremor in Patients with Amyloidosis Than in the General Population
Thomas Ford, MD
12:00 PM - 01:00 PM Abstract 3-004 - Elderly Diagnosis of Essential Tremor as a Possible Confound for Prodromal Parkinson's Disease
Joseph Seemiller, MD
12:00 PM - 01:00 PM Abstract 3-005 - Characterization of Tremor in Children Using Accelerometry and The Kinarm.
Alex J. Medina Escobar, MD
12:00 PM - 01:00 PM Abstract 3-006 - Treatment Patterns in Patients with Essential Tremor
Chintan Shah, MD
12:00 PM - 01:00 PM Abstract 3-007 - Mechanistic PK/PD Model of Neuroactive Steroid GABAA Positive Allosteric Modulation and Effects on TETRAS Assessment in Essential Tremor
12:00 PM - 01:00 PM Abstract 3-008 - A case of Klienfelter Syndrome With Chromosome 3 Anomaly presenting with Linguo-Palato-Perioral Tremor
Sajish Jacob, MBBS
12:00 PM - 01:00 PM Abstract 3-009 - Prevalence of Cognitive Impairment among Essential Tremor patients
Susana Lopez
12:00 PM - 01:00 PM Abstract 3-010 - Gaps in the Management of Cervical Dystonia with Botulinum Toxin A: Findings from an Online Patient Survey
Cynthia L. Comella, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 3-011 - ANO3 Mutations in Chinese Dystonia: a Genetic Screening Study Using Next-Generation Sequencing
Shanglin Li, MD
12:00 PM - 01:00 PM Abstract 3-012 - DYT-TUBB4A (DYT4 dystonia): New Genetic and Clinical Observations in three Families
Julien F. Bally, MD
12:00 PM - 01:00 PM Abstract 3-014 - Botulinum Toxin Overdoses and Association with Medication Errors
Rashid Kazerooni
12:00 PM - 01:00 PM Abstract 3-015 - Management and Quality of Life of Dystonia Patients in Europe: A Survey Towards Care from a Patients’ Experience
Maja Relja, MD
12:00 PM - 01:00 PM Abstract 3-016 - CBIT response in clinical practice: The potential importance of comorbidities and tic location
Shannon Y. Chiu, MD, MSc
12:00 PM - 01:00 PM Abstract 3-017 - Cost-Analysis of the Use of IncobotulinumtoxinA and AbobotulinumtoxinA for the Treatment of Post-Stroke Upper Limb Spasticity Based on Recommended Dosing for Muscles and Clinical Patterns
Marie-Eve Gendron
12:00 PM - 01:00 PM Abstract 12-001 - Hospital readmissions in older adults with epilepsy in the US - a population-based study
Cristina Schreckinger, MD
12:00 PM - 01:00 PM Abstract 12-002 - Outcome of Epilepsy in Older Adults; Preliminary Analysis
Ajaz Sheikh, MD
12:00 PM - 01:00 PM Abstract 12-003 - Are seizures associated with increased odds of 30-day readmission after Traumatic Brain Injury? Evidence from the National Readmission Database 2014.
Alain Z. Lekoubou Looti, MD
12:00 PM - 01:00 PM Abstract 12-004 - National Institute of Neurological Disorders and Stroke Epilepsy Common Data Element Updates: Seizure Severity Instruments, Diagnostic Tools, and MRI Recommendations
Katelyn E. Gay
12:00 PM - 01:00 PM Abstract 12-005 - Reducing seizure burden significantly improves patient reported outcomes and decreases health resource utilization amongst patients with convulsive seizures.
Shehryar Sheikh
12:00 PM - 01:00 PM Abstract 12-006 - Communication Among Adult Patients Living With Epilepsy, Caregivers, and Healthcare Professionals: A 2-way Street?
Nancy Santilli, RN, PNP, MN
12:00 PM - 01:00 PM Abstract 12-007 - Incidence of Anti-Epileptic Drug Related Falls
12:00 PM - 01:00 PM Abstract 12-008 - Computational analysis of Seizure Clusters in electronic diary free text notes
Katherine Werbaneth, MD
12:00 PM - 01:00 PM Abstract 12-009 - Perspectives on Epilepsy-Related Fears Among Adult Patients Living With Epilepsy, Caregivers, and Healthcare Professionals
John M. Stern, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 12-010 - Poor Epilepsy Self Management and Self Efficacy Skills in EMU Patients
HaeWon Shin, MD
12:00 PM - 01:00 PM Abstract 6-001 - Neuroimaging-Guided Thrombolytic Treatment in Wake-Up Stroke: A Literature Review.
Mohamed Elfil, MBBCh
12:00 PM - 01:00 PM Abstract 6-002 - Association between Helicobacter pylori Infection and Stroke: A Systematic review and Meta-analysis of Observational Studies
Mohamed Fahmy Doheim
12:00 PM - 01:00 PM Abstract 6-003 - Circadian Rhythm Pattern Of Stroke : Study From Sudan.
Tahir H. Obeid, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 6-004 - Homocysteine: A Potential Risk Factor for Peripheral Neuropathy
Rebecca T. Hsu, MD
12:00 PM - 01:00 PM Abstract 6-005 - Intraepidermal nerve fiber densitiy in non-diabetic with and without antecedents of DM2 in comparision with diabetic patients at the center of Mexico
12:00 PM - 01:00 PM Abstract 6-006 - Spinal epidural lipomatosis with progressive myelopathy in patients with Type 1 Diabetes Mellitus: a novel association?
Ilya Kister, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 6-007 - Dynamic Cerebral Autoregulation in Patients with Type 2 Diabetes Mellitus
Myint T. Naing, FRCP, DrMedSc
12:00 PM - 01:00 PM Abstract 6-008 - Semi-Automatic Analysis of the Cytoarchitecture in Brodmann Area 23Ventral of the Posterior Cingulate Gyrus
Nicholas Tost
12:00 PM - 01:00 PM Abstract 6-009 - Facial Nerve Enhancement on MRI Associated With A Longer Course of Bell’s Palsy?
Nestor Beltre, MD
12:00 PM - 01:00 PM Abstract 6-010 - The association of dilated perivascular spaces (PVS) and microstructural white matter integrity:A Population-Based Study
Zi-Yue Liu
12:00 PM - 01:00 PM Abstract 6-011 - Neurological Complications After Liver Transplantation: An Argentinian Cohort.
Miguel A. Saucedo, MD
12:00 PM - 01:00 PM Abstract 7-001 - Impact of Primary Headache Disorder on Quality of Life Among School Children in Kuwait
12:00 PM - 01:00 PM Abstract 7-002 - Clinical Predictors associated with Persistent versus Acute Post-Traumatic Headache
Lik Hang Tommy Chan, MD
12:00 PM - 01:00 PM Abstract 7-003 - The clinical characteristics of new daily persistent headache in childhood: a matched case control study.
Priyanka Shekhawat, MD
12:00 PM - 01:00 PM Abstract 7-004 - The State of the Headache Fellowship Application Process and Attitudes towards the Match: Interview of US Headache Fellowship Program Directors
Niushen Zhang, MD
12:00 PM - 01:00 PM Abstract 7-005 - Resilience and Vulnerability in Adolescents with Chronic Headache: a Population Study
Renato Arruda, MD
12:00 PM - 01:00 PM Abstract 7-006 - Patient-Reported Sensitivity to Medications in a Headache Specialty Clinic
Natalia Murinova, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 7-007 - Headache Characteristics in the Post-partum of Patients with Hypertensive Complications During Pregnancy.
12:00 PM - 01:00 PM Abstract 7-008 - Cerebrospinal Fluid Leak in the context of Pars Interarticularis Fracture: A Case Series
Lik Hang Tommy Chan, MD
12:00 PM - 01:00 PM Abstract 7-009 - Introducing the National Headache Medicine Fellowship Opportunities Website
Niushen Zhang, MD
12:00 PM - 01:00 PM Abstract 7-010 - Using Pediatric Quality of Life (PedsQL) Survey to Guide Headache Disorder Management and Gauge Treatment: One Institution’s Ongoing Experience.
Thara Bala, MD
12:00 PM - 01:00 PM Abstract 7-011 - A Retrospective Cohort Study of Urgent Care Visits and Revisits for Headache and Migraine in New York City
Kina Zhou
12:00 PM - 01:00 PM Abstract 7-012 - Impact of Pubertal Status on the Prevalence of Primary Headache Disorder Among Female School Children in Kuwait.
12:00 PM - 01:00 PM Abstract 1-001 - Immunomodulatory and Anti-oxidative Effect of the Direct TRPV1 Receptor Agonist Capsaicin on Schwann Cells
Kalliopi Pitarokoili, MD
12:00 PM - 01:00 PM Abstract 1-002 - Acetylcholine Receptor Antibodies in a patient with Sensory Neuropathy
Shitiz K. Sriwastava, MBBS
12:00 PM - 01:00 PM Abstract 1-003 - Rapidly Progressive Dorsal Cord Syndrome: A Case Of Synergistic Multinutrient Deficiency
Benjamin Lin
12:00 PM - 01:00 PM Abstract 1-004 - Triple M: A case of Nivolumab-induced myasthenic crisis, myocarditis and myositis
Katelyn Oliveira, DO
12:00 PM - 01:00 PM Abstract 1-005 - Vanishing Muscle; A Disappearing Act and Its Multiple Etiologies
Sonia M. Caraballo-Cartagena, MD
12:00 PM - 01:00 PM Abstract 1-006 - Understanding Mitochondrial DNA Maintenance Disorders at the Single Muscle Fibre Level
12:00 PM - 01:00 PM Abstract 1-007 - A New Case Of Spastic Paraplegia Type 64 Due To A Missense Mutation In The ENTPD1 Gene
Alier Marrero, MD
12:00 PM - 01:00 PM Abstract 1-008 - A Novel Dominant HSPD1 Mutation In Hereditary Spastic Paraplegia Complicated by Leukoencephalopathy And Cognitive Dysfunction
Mika Martikainen
12:00 PM - 01:00 PM Abstract 1-009 - Clinical and genetic features of SPG11: A Single Center Experience
Arman Cakar
12:00 PM - 01:00 PM Abstract 1-010 - Botulinum Toxin in the Management of Refractory Sialorrhea in Patients with Neuromuscular Disease
Harsh Singh
12:00 PM - 01:00 PM Abstract 1-011 - Novel approaches for quantifying muscle disuse: A study of rotator cuff injury
Akashleena Mallick, MD, MBBS
12:00 PM - 01:00 PM Abstract 1-012 - Spherical Nucleic Acids (SNAs) for the Treatment of Neurologic Diseases
Grant T. Corbett, PhD
12:00 PM - 01:00 PM Abstract 1-013 - A Novel Homozygous TRIM32 Mutation in a Non-Hutterite Patient with Limb-Girdle Muscular Dystrophy
Pritikanta Paul, MD
12:00 PM - 01:00 PM Abstract 1-014 - Dual mutation- CLCN-1 and Col12A1 with clinical Myotonia
Maria Sarfraz, MBBS
12:00 PM - 01:00 PM Abstract 1-015 - Stiff Limb Syndrome: A Rare Variant of Stiff Person's Syndrome
Benjamin Lin
12:00 PM - 01:00 PM Abstract 10-001 - Fatal Neurologic Complication of Schizophrenia and Psychogenic Polydipsia: A Case Report
Erin R. Fiedler, DO
12:00 PM - 01:00 PM Abstract 10-002 - Non-Alcoholic Wernicke’s Encephalopathy in a Middle-aged Male Presenting with Psychosis
Ana Verdecia, MD
12:00 PM - 01:00 PM Abstract 10-003 - An Unusually Rapid Onset and Fulminant Course of Sporadic Creutzfeldt-Jakob Disease in a Young Patient
Smeer Salam, MD, MBBS
12:00 PM - 01:00 PM Abstract 10-004 - Alcoholic Wernicke’s Encephalopathy Presenting with Isolated Cerebellar Diffusion Restriction
Gaurav Thakur, DO
12:00 PM - 01:00 PM Abstract 10-005 - Moderate-Severe TBI as a Progressive Disorder: Cognitive declines in the Chronic Stages of Injury
12:00 PM - 01:00 PM Abstract 10-006 - Impact of Season on Disability and Related Measures in Older Adults: A Cross-Sectional Observational Study
Rebecca Wu, MD
12:00 PM - 01:00 PM Abstract 10-007 - The North American Prodromal Synucleinopathy (NAPS) Consortium: Baseline Neuropsychological Findings in 70 Participants
Julie A. Fields, PhD
12:00 PM - 01:00 PM Abstract 10-008 - Personality Traits as Predictors of Pre-dementia Syndromes in Older Adults.
Emmeline Ayers, MPH
12:00 PM - 01:00 PM Abstract 10-009 - Intrusions in episodic memory in preclinical autosomal dominant Alzheimer’s disease: Contributions of education and occupation to optimal recall
Liliana A. Ramirez-Gomez, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 10-010 - Assessing the effectiveness of SCD-plus criteria in predicting the progression to Alzheimer’s Disease: A 10-year follow-up study.
Salvatore Mazzeo
12:00 PM - 01:00 PM Abstract 10-011 - Validation of SATURN; an Inexpensive, Freely-available, and Fully Self-administered Cognitive Screening Test.
David P. Bissig, MD
12:00 PM - 01:00 PM Abstract 10-012 - Assessment of short-term memory using a gamified tablet-based task
Younes Adam Tabi
12:00 PM - 01:00 PM Abstract 4-001 - Albuminuria Detection and Management in Patients admitted with Ischemic Stroke and Intracranial Hemorrhage: A Pilot Quality Assurance Project to Target Reduction of Recurrent Stroke Risk.
Steven C. Yang, DO
12:00 PM - 01:00 PM Abstract 4-002 - Improving Outcomes for In-Hospital Stroke: A Single Center Study
Angela M. Hawkins, RN
12:00 PM - 01:00 PM Abstract 4-003 - The “weekend effect” – Does it impact acute stroke care?
Anand V. Patel, MD
12:00 PM - 01:00 PM Abstract 4-004 - The Effects of Thrombolysis and Thrombectomy on Patient-centered Non-modified Rankin Scale (mRS) Outcome Measures in Patients with Minor-moderate Stroke: A Systematic Review
Adam Book, MD
12:00 PM - 01:00 PM Abstract 4-005 - Data Mining applied to Poststroke Depression in Colombian Elderly Patients
Gabriel D. Pinilla Monsalve, MD, MSc
12:00 PM - 01:00 PM Abstract 4-006 - Head-to-head comparison of social network assessments in stroke survivors
Simona Nedelcu, MD, PhD
12:00 PM - 01:00 PM Abstract 4-007 - Remote Management of Post-stroke Patients with Smartphone-based Management System Integrated in Clinical Care
12:00 PM - 01:00 PM Abstract 4-008 - Aphemia Following a Non-dominant Sub-insular Stroke: Unveiling the Foix-Chavany-Marie Phenomenon
Saurav Das, MD
12:00 PM - 01:00 PM Abstract 4-009 - An Inpatient Scoring System To Prevent Hospital Acquired Pneumonia on Stroke Service
Mudassir Farooqui, MD
12:00 PM - 01:00 PM Abstract 4-010 - Factors And Hospital Charges Associated With Prolonged Length Of Hospitalization In Patients Admitted With Ischemic Stroke In The United States
12:00 PM - 01:00 PM Abstract 4-011 - Stroke Characteristics in Post-Stroke Epilepsy Cohort: A Single Center Experience
Ka-Ho Wong
12:00 PM - 01:00 PM Abstract 4-012 - Ischemic Stroke Strikes Autonomic Nervous System
12:00 PM - 01:00 PM Abstract 4-013 - National Estimates Of Recurrent Ischemic Stroke Among Patients Undergoing Carotid Revascularization: Effect Of Treatment Modality
Sairah Bashir, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 4-014 - Inpatient Complications and Mortality of Stroke in Costa Rica: A seven-year hospital-based acute stroke registry of 1319 patients
Cesar E. Escamilla-Ocanas, MD
12:00 PM - 01:00 PM Abstract 4-015 - Shorter Hospital Stays are Associated with Undiagnosed Diabetes in Ischemic Cerebrovascular Patients
Coleton Towles
12:00 PM - 01:00 PM Abstract 4-016 - Predicting Outcome in Acute Posterior Circulation Strokes treated with Interventional Thrombectomy in a Middle Eastern Stroke Center
Tehniyat Baig, MD
12:00 PM - 01:00 PM Abstract 4-017 - Patterns of Domain-Specific Recovery Over 90 days from Acute Ischemic Stroke Onset
12:00 PM - 01:00 PM Abstract 4-018 - Does Age Affect Functional Improvement in Stroke Patients During Inpatient Rehabilitation?
Shayandokht Taleb, MD
12:00 PM - 01:00 PM Abstract 13-001 - Contiguous Neurosciences Intensive Care Unit (NSICU) Admissions and Patient Outcomes
12:00 PM - 01:00 PM Abstract 13-002 - Ventilator Associated Pneumonia Incidence with different Positive End-Expiratory Pressure (PEEP) settings in a Neurological ICU serving rural patients
Klepper Alfredo Garcia, MD
12:00 PM - 01:00 PM Abstract 13-003 - A Rare Case Of Dysferlinopathy With Recurrent Rhabdomyolysis
Subhendu Rath, MBBS
12:00 PM - 01:00 PM Abstract 13-004 - Serotonin Syndrome with Exposure from Tetrahydrocannabinol: a Case Report to Highlight the Side Effects of Increasing Use of CBD Products
12:00 PM - 01:00 PM Abstract 13-005 - Innovative Multi-Approach Therapy for Treatment of Central Pontine Myelinolysis
Chelsea C. Yager, PA
12:00 PM - 01:00 PM Abstract 13-006 - Ketone Bodies Induce Oxidative Stress and Apoptosis on Human Microglial Cell Line
Nizar Souayah, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 13-007 - A Healthy Young Man With Headache and Trochlear Nerve Palsy – “The Great Masquerader” presenting as Tuberculous Meningitis: A Case Report
Olga Gomez Siegert, MD
12:00 PM - 01:00 PM Abstract 13-008 - Case Report: Intracranial Miliary Metastatic Disease in a Patient with Primary Ductal Carcinoma of the Breast
Belle V. English, MD
12:00 PM - 01:00 PM Abstract 13-009 - Does Insurance Status of Patients Treated in a Neurocritical Care Facility Affect the Length of their Hospital Stay? One Hospital’s Experience
Ian Cossentino, BS
12:00 PM - 01:00 PM Abstract 13-011 - Refractory Orolingual Angioedema after Alteplase Treatment: A Novel Approach
Martha Robinson, MD
12:00 PM - 01:00 PM Abstract 13-012 - Clopidogrel versus Prasugrel towards Prevention of Stent Thrombosis of Intracranial Aneurysm – A metanalysis and literature review
12:00 PM - 01:00 PM Abstract 13-013 - Shorter intensive care unit stay (12 hours) post thrombolysis is safe and reduces length of stay for minor stroke patients
Muhib Khan, MD, FÂ鶹´«Ã½Ó³»­
12:00 PM - 01:00 PM Abstract 13-014 - Escaping the web: Antiplatelet insufficient for stroke prevention in Carotid Artery Web
Charles D. Schutt, MD
12:00 PM - 01:00 PM Abstract 13-015 - Opioid use during hospitalization for Subarachnoid Hemorrhage is associated with continued use at follow up
Matthew N. Jaffa, DO
12:00 PM - 01:00 PM Abstract 13-016 - EEG Sleep Architecture as a Biomarker after Non-traumatic Subarachnoid Hemorrhage
Christopher Wilkins, MD
12:00 PM - 01:00 PM Abstract 13-017 - Steroids have mild transient effects on headache in patients with Subarachnoid Hemorrhage
Arshom Foroutan
12:00 PM - 01:00 PM Abstract 13-018 - Safety and Clinical Outcome of Good-Grade Aneurysmal Subarachnoid Hemorrhage in Non-Intensive Care Units
Jose Danilo B. Diestro, MD
12:00 PM - 01:00 PM Abstract 5-001 - Movement Disorders in Women with X-Linked Adrenoleukodystrophy
Melanie Leigh D. Supnet, MD
12:00 PM - 01:00 PM Abstract 5-002 - Cannabidiol Transdermal Gel for the Treatment of Fragile X Syndrome: Post hoc Responder Analysis and Pattern of Efficacy on domains of the Aberrant Behavior Checklist-FXS (ABC-CFXS)
Joseph M. Palumbo, MD
12:00 PM - 01:00 PM Abstract 5-003 - Central Nervous System/Vestibular abnormalities in Oculo-Auriculo-Vertebral Spectrum Disorders
Jyotika Singh
12:00 PM - 01:00 PM Abstract 5-004 - Early Clinical Experience with Onasemnogene Abeparvovec in Spinal Muscular Atrophy (SMA) Type 2 Patients at a Single Center
Susan Matesanz, MD
12:00 PM - 01:00 PM Abstract 5-005 - Real-World Treatment Patterns and Outcomes in Patients with Spinal Muscular Atrophy Collected from the RESTORE Registry
Laurent Servais
12:00 PM - 01:00 PM Abstract 5-006 - Sex Difference in a New Mild Mouse Model of Spinal Muscular Atrophy
Marc-Olivier Deguise
12:00 PM - 01:00 PM Abstract 5-007 - A Search for Systemic Manifestations of Spinal Muscular Atrophy (SMA): A Matched-Cohort Study Using Insurance Claims Data in the USA
12:00 PM - 01:00 PM Abstract 5-008 - Assessment of Awareness of the Early Clinical Features of Spinal Muscular Atrophy (SMA) Amongst Neurology and Child Neurology Residents and Fellows
Rosangel E. Cruz, MA
12:00 PM - 01:00 PM Abstract 5-009 - Identical twins with progressive gait disturbance due to a novel SPG11 mutation
Rahul D. Abhyankar, MD
12:00 PM - 01:00 PM Abstract 5-010 - Characterizing commercially- and Medicaid-insured registrants with Duchenne muscular dystrophy (DMD) in the United States (US)
12:00 PM - 01:00 PM Abstract 5-011 - Understanding the Role of the DMD Protein Dystrophin in the Subventricular Zone
Andrea J. Arreguin
12:00 PM - 01:00 PM Abstract 5-012 - Deflazacort Or Prednisone Treatment for Duchenne Muscular Dystrophy (DMD) Real-World Outcomes at Cincinnati Children’s Hospital Medical Center (CCHMC)
12:00 PM - 01:00 PM Abstract 5-013 - Improved Metabolic and Bone Health in Boys with Duchenne Muscular Dystrophy Treated with High Dose Pulse Weekend Corticosteroids compared to Daily Dosing
Aaron Zelikovich, MD
12:00 PM - 01:00 PM Abstract 5-014 - Promising Results for Kearns-Sayre Syndrome of First in Man Treatment by Mitochondrial Augmentation Therapy
12:00 PM - 01:00 PM Abstract 5-015 - "MEGAS": Mitochondrial Encephalopathy, Gastric Dysmotility, and Seizures
Marika Antimisiaris, MD
Faculty Disclosures
Elan D. Louis, MD, MS, FÂ鶹´«Ã½Ó³»­ Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Adam De Havenon, MD, FÂ鶹´«Ã½Ó³»­ Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Robert S. Fisher, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epi-Minder Study, Australia (Mark Cook, PI). Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for START study (Hal Blumenfeld, PI). Dr. Fisher has stock in Avails Medical stock options (drug level testing). Dr. Fisher has stock in Eysz stock options (eye-movement seizure detection). Dr. Fisher has stock in Irody stock options (health records databases). Dr. Fisher has stock in Smart-Monitor stock options (shake-detector watch). Dr. Fisher has stock in Zeto stock options, dry, wireless EEG. The institution of Dr. Fisher has received research support from NaviFUS (focused ultrasound).
Ruth-Ann Marrie, MD, PhD The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Jeffrey L. Bennett, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immpact Bio. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chugai. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beigene. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIAC. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CorEvitas. Dr. Bennett has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vindico. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Touch IME. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Efficient LLC. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Pavich. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Marie Bush. Dr. Bennett has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Marks Gray. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Knight, Nicastro, MacKay. The institution of Dr. Bennett has received research support from Alexion. The institution of Dr. Bennett has received research support from Genentech. Dr. Bennett has received intellectual property interests from a discovery or technology relating to health care. Dr. Bennett has received publishing royalties from a publication relating to health care.
Laurie J. Ozelius, PhD The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Bruce I. Ovbiagele, MD, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
HaeWon Shin, MD The institution of Dr. Shin has received research support from NIH RO1. The institution of Dr. Shin has received research support from NIH U Grant. The institution of Dr. Shin has received research support from UCB. The institution of Dr. Shin has received research support from Biogen. The institution of Dr. Shin has received research support from Neuropace. The institution of Dr. Shin has received research support from Praxis Precision Medicine.
David J. Adams, MD No disclosure on file
Matilde Inglese, MD, PhD Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Richard S. Finkel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Gunjan Parikh, MD The institution of Dr. Parikh has received research support from Department of Defense. The institution of Dr. Parikh has received research support from NINDS. The institution of Dr. Parikh has received research support from NIH.
No disclosure on file
Xavier Ayrignac Xavier Ayrignac has nothing to disclose.
John Liang, MD Dr. Liang has nothing to disclose.
Lara Jehi, MD Dr. Jehi has nothing to disclose.
Sean I. Savitz, MD Dr. Savitz has nothing to disclose.
Darryl C. De Vivo, MD, FÂ鶹´«Ã½Ó³»­ Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Natalia Murinova, MD, FÂ鶹´«Ã½Ó³»­ Dr. Murinova has nothing to disclose.
Brandon P. Moss, MD An immediate family member of Dr. Moss has stock in Pfizer. The institution of Dr. Moss has received research support from Novartis. The institution of Dr. Moss has received research support from Genentech.
Fatma Yesim Parman, MD Dr. Parman has nothing to disclose.
Huberth Fernandez No disclosure on file
Albert Robichaud, PhD No disclosure on file
Daniel H. Lowenstein, MD Dr. Lowenstein has received research support from NIH.
Albert C. Ludolph, MD Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Ludolph has received personal compensation in the range of $0-$499 for serving as a Consultant for FundaMental Pharma . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon . Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharma. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biologix FZCo.. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ludolph has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon.
Maria Trojano Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
John M. Stern, MD, FÂ鶹´«Ã½Ó³»­ Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Angela Wabulya, MB ChB Dr. Wabulya has nothing to disclose.
Michael S. Okun, MD, FÂ鶹´«Ã½Ó³»­ Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Neha Dangayach, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dangayach has nothing to disclose.
Helmi L. Lutsep, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lutsep has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lutsep has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Coherex Medical. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/Mayo Cinic. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape Neurology.
Deniz Erten-Lyons, MD, FÂ鶹´«Ã½Ó³»­ Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals.
Hacer Durmus, MD Dr. Durmus has nothing to disclose.
Zulma M. Hernandez-Peraza, MD No disclosure on file
Alison L. Walsh, MD Dr. Walsh has nothing to disclose.
Kailash P. Bhatia, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bhatia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Bhatia has received publishing royalties from a publication relating to health care.
Walter A. Kukull, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Kukull has received research support from NIH/NIA. Dr. Kukull has a non-compensated relationship as a Associate editor with Alzheimer's and Dementia TRCI (journal) that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Kukull has a non-compensated relationship as a Editorial board with Journal of American Geriatrics Soc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Andrew Lim, MD Dr. Lim has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Canada.
David Z. Rose, MD Dr. Rose has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Boston Scientific. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Chiesi USA. Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Rose has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Boehringer Ingelheim . Dr. Rose has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL-Behring .
Mitzi J. Williams, MD, FÂ鶹´«Ã½Ó³»­ Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen Idec. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis Pharmaceuticals. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has a non-compensated relationship as a National Board Member with National MS Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Williams has a non-compensated relationship as a Board Trustee with Consortium of MS Centers that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Williams has a non-compensated relationship as a Board Chair with Joi Life Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Anita K. Mehta, MD Dr. Mehta has nothing to disclose.
Swetha Renati, MD Dr. Renati has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Renati has received personal compensation in the range of $500-$4,999 for serving as a NeuroSAE with Â鶹´«Ã½Ó³»­ .
Dirk W. Dressler, MD No disclosure on file
Reinhard Hohlfeld, MD Dr. Hohlfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
Neeraj Badjatia, MD The institution of Dr. Badjatia has received research support from NIH/DOD.
Hayrettin Tumani, MD Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Nutan Sharma, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Sharma has nothing to disclose.
Hsien Lee Lau, MD No disclosure on file
Patricia E. Penovich, MD, FÂ鶹´«Ã½Ó³»­ Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engage therapeutics. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for LVIS. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for Monteris. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Therapeutics. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Penovich has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Greenwich. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Biosciences. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Penovich has a non-compensated relationship as a Comittee Member with American Epilepsy Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Wissam G. Deeb, MD, FÂ鶹´«Ã½Ó³»­ Dr. Deeb has a non-compensated relationship as a Board member with Davis Phinney Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Clarisse Carra-Dalliere No disclosure on file
Feride H. Frech, PhD Dr. Frech has received personal compensation for serving as an employee of Eisai Inc.
Anne Smith Anne Smith has received personal compensation for serving as an employee of Ionis Pharmaceuticals.
Abdul J. Sankoh, PhD No disclosure on file
Sonia M. Caraballo-Cartagena, MD Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Caraballo-Cartagena has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Caraballo-Cartagena has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alnylam. Dr. Caraballo-Cartagena has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx.
Shayandokht Taleb, MD Dr. Taleb has nothing to disclose.
Douglas L. Arnold, MD, FÂ鶹´«Ã½Ó³»­ Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Aleksandar Videnovic, MD, MSc, FÂ鶹´«Ã½Ó³»­ Dr. Videnovic has nothing to disclose.
Arthur D. Mauricio No disclosure on file
Ronald Postuma, MD Dr. Postuma has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche, Biogen, Takeda, Theranexus, GE, Jazz, Curasen, Paladin, Inception Sciences, Phytopharmics, Vaxxinity, Merck. Dr. Postuma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen/Partners. The institution of Dr. Postuma has received research support from CIHR, Weston Foundation, Webster Foundation, Roche, MJFF, Parkinson Canada, FRSQ, NIH.
Bruce A. Cree, MD, PhD, MAS, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Vijayshree Yadav, MD, FÂ鶹´«Ã½Ó³»­ Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Matthew A. Tremblay, MD Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals Inc. Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Tremblay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. The institution of Dr. Tremblay has received research support from Biogen Inc. Dr. Tremblay has received publishing royalties from a publication relating to health care.
Aksel Siva, MD Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants.
Jennifer A. Tracy, MD Dr. Tracy has nothing to disclose.
Raed Alroughani, MD, FÂ鶹´«Ã½Ó³»­ Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Deborah M. Miller, PhD Dr. Miller has received intellectual property interests from a discovery or technology relating to health care.
Marco A. Arruda, MD, PhD No disclosure on file
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Annie S. Daniel, MBBS Dr. Daniel has nothing to disclose.
Aimee M. Aysenne, MD, MPH Dr. Aysenne has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ceribell. Dr. Aysenne has received stock or an ownership interest from Teledoc. Dr. Aysenne has received stock or an ownership interest from Pfizer.
Khan Farid No disclosure on file
Nazli Basak No disclosure on file
Maria Pia Sormani Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol meyer. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Lucretia Long, DNP, APRN-CNP, FAES Mrs. Long has received personal compensation for serving as an employee of SKLife. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SKLife. Mrs. Long has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst Pharmaceutical. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Liva Nova. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Mrs. Long has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK lIFE. Mrs. Long has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Liva Nova.
David P. Bissig, MD Dr. Bissig has received personal compensation in the range of $100,000-$499,999 for serving as a Physician with University of California - Davis.
Subhendu Rath, MBBS Dr. Rath has nothing to disclose.
Rahul Damani Rahul Damani has nothing to disclose.
Angela Wehr No disclosure on file
Elif Bayraktar No disclosure on file
Tamara M. Pringsheim, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Douglas M. Turnbull No disclosure on file
Maja Relja, MD No disclosure on file
Jin J. Luo, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Luo has nothing to disclose.
Michelle Cameron, MD Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Liying Cui, PhD No disclosure on file
Harold H. Morris III, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Bradley F. Boeve, MD, FÂ鶹´«Ã½Ó³»­ Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Michael J. Howell, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Howell has received research support from National Institutes of Health. Dr. Howell has received publishing royalties from a publication relating to health care.
Deborah I. Friedman, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Friedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsone. Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology . Dr. Friedman has a non-compensated relationship as a Program Co-Chair, Scottsdale Headache Symposium with American Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Friedman has a non-compensated relationship as a Medical Advisor with Spinal CSF Leak Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Friedman has a non-compensated relationship as a President-elect, Board of Directors with Southern Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Camilo R. Gomez, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gomez has nothing to disclose.
Emmanuel Roze, MD, PhD Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merz. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Roze has received research support from merz. The institution of Dr. Roze has received research support from Orkyn. Dr. Roze has received research support from elivie. The institution of Dr. Roze has received research support from allergan. The institution of Dr. Roze has received research support from fondation desmarest. The institution of Dr. Roze has received research support from everpharma. Dr. Roze has received research support from AMADYS. The institution of Dr. Roze has received research support from ADCY5.org. The institution of Dr. Roze has received research support from agence nationale de la recherche. The institution of Dr. Roze has received research support from société française de médecine esthétique. The institution of Dr. Roze has received research support from dystonia medical research foundation.
Michal Kral No disclosure on file
Yan Zhang, MD No disclosure on file
Ka-Ho Wong The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Priyanka Shekhawat, MD Dr. Shekhawat has nothing to disclose.
Claudio Santos No disclosure on file
Elizabeth A. Kichula, MD, PhD No disclosure on file
Joaquim Ferreira No disclosure on file
Jessica Rice, MD Dr. Rice has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals.
Luis Fernandez No disclosure on file
Prabhdeep Singh, MD No disclosure on file
Sarah Verga Miss Verga has nothing to disclose.
Davide Martino, MD, PhD Dr. Martino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Martino has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merz Pharma Canada Ltd..
Rebecca Spain, MD, MSPH, FÂ鶹´«Ã½Ó³»­ Dr. Spain has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for United States Department of Justice. The institution of Dr. Spain has received research support from Department of Veterans Affairs. The institution of Dr. Spain has received research support from National Multiple Sclerosis Society.
Robert Cowan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohavenn. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbviie. Dr. Cowan has stock in Percept. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received publishing royalties from a publication relating to health care.
Cynthia L. Comella, MD, FÂ鶹´«Ã½Ó³»­ Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Francisco J. Lopera Restrepo, MD, PhD No disclosure on file
Kara Stavros, MD, FÂ鶹´«Ã½Ó³»­ Dr. Stavros has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare LLC. Dr. Stavros has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Rhode Island Medical Society.
Lawrence J. Hirsch, MD, FÂ鶹´«Ã½Ó³»­ Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. The institution of Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport Therapeutics. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received publishing royalties from a publication relating to health care. Dr. Hirsch has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker; Faculty for Fellows' training course with Neuropace. Dr. Hirsch has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Natus.
Stephen J. Kolb, MD, PhD Dr. Kolb has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AveXis. Dr. Kolb has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for CureSMA. The institution of Dr. Kolb has received research support from NIH. The institution of Dr. Kolb has received research support from AveXis. The institution of Dr. Kolb has received research support from NIH.
Ricardo C. Reisin, MD Dr. Reisin has nothing to disclose.
Stephanie Cosentino, PhD Dr. Cosentino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for Frontotemporal Dementia. Dr. Cosentino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAGE Pharmaceuticals.
Mudassir Farooqui, MD Dr. Farooqui has nothing to disclose.
Maria S. Pacha No disclosure on file
Enrique Alvarez, MD, PhD Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Alvarez has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Alvarez has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Alvarez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene/BMS. The institution of an immediate family member of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Alvarez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Timothy L. Vollmer, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Brian Koo, MD Dr. Koo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Regent. Dr. Koo has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Speckhals Law. The institution of Dr. Koo has received research support from Department of Defense.
Sean Selva Sean Selva has nothing to disclose.
Kalliopi Pitarokoili, MD Dr. Pitarokoili has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring.
Samar F. Ahmed, MD Dr. Ahmed has nothing to disclose.
Anibal Chertcoff Anibal Chertcoff has nothing to disclose.
Mark E. Pierce, MD Dr. Pierce has nothing to disclose.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Casey R. Dunn, MD No disclosure on file
Simona Nedelcu, MD, PhD No disclosure on file
Kasser Saba, MD Dr. Saba has nothing to disclose.
Nico Papinutto No disclosure on file
Fei Han Fei Han has nothing to disclose.
Leah K. Forsberg, PhD Ms. Forsberg has nothing to disclose.
Kevin R. Nelson, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Christopher William Christopher William has nothing to disclose.
Seward B. Rutkove, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
John Cole, MD Dr. Cole has nothing to disclose.
Joyce A. Cramer No disclosure on file
Hardik Amin, MD No disclosure on file
Alier Marrero, MD Dr. Marrero has nothing to disclose.
Ava Giugliano, DO No disclosure on file
Aarti Sarwal, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stimdia, Inc. Dr. Sarwal has received personal compensation in the range of $0-$499 for serving as a Consultant for Sheinkei. Dr. Sarwal has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Society of Neuroimaging . The institution of Dr. Sarwal has received research support from Butterfly, Inc. The institution of Dr. Sarwal has received research support from Bard. The institution of Dr. Sarwal has received research support from Biogen. The institution of Dr. Sarwal has received research support from Novartis. The institution of Dr. Sarwal has received research support from CVR Global. The institution of Dr. Sarwal has received research support from NIH/NIA R01 AG066910-01 . The institution of Dr. Sarwal has received research support from Image Monitoring. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Faculty, CME courses with Society of Critical Care Medicine . Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Intensive Care Society. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker at annual congress with Indian Society of Critical Care. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a speaker/Faculty for Annual meeting, travel compensation with European Society of Intensive Care Medicine. Dr. Sarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ISICEM. Dr. Sarwal has a non-compensated relationship as a Social Media Editor with Neurocritical Care that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Sarwal has a non-compensated relationship as a Secretary with American Society of Neuroimaging that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Sarwal has a non-compensated relationship as a President with Association of Indian Neurologists in America that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Sarwal has a non-compensated relationship as a Member, Board of Directors with Neurocritical Care Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Sarwal has a non-compensated relationship as a Section Chair, Neurosciences Section with Society of Critical Care Medicine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Bradford B. Worrall, MD, MSc, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Worrall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. The institution of Dr. Worrall has received research support from NIH. The institution of Dr. Worrall has received research support from AHA/ASA.
Emily S. Riser, MD Dr. Riser has nothing to disclose.
Melissa Sgodzai Melissa Sgodzai has nothing to disclose.
Jason P. Mendoza, PhD Dr. Mendoza has received personal compensation for serving as an employee of Biogen. Dr. Mendoza has stock in Biogen.
Ann Murray, MD Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Murray has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Robert H. Gross, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gross has nothing to disclose.
Mohammed Kananeh, MD Dr. Kananeh has nothing to disclose.
Torge Rempe, MD Dr. Rempe has nothing to disclose.
Alon Y. Avidan, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Avidan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avadel. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Avidan has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Avidan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Harmony. Dr. Avidan has received publishing royalties from a publication relating to health care.
Xiaohong Si, MD Dr. Si has nothing to disclose.
Joachim Krauss No disclosure on file
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Nancy L. Kuntz, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
Belle V. English, MD No disclosure on file
Steven C. Cramer, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cramer has received personal compensation for serving as an employee of University of California. An immediate family member of Dr. Cramer has received personal compensation for serving as an employee of University of California. Dr. Cramer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astellas, Alevian, Bayer, BlueRock Therapeutics, BrainQ, Constant Therapeutics, Medtronic, MicroTransponder, Myomo, Myrobalan, NeuroTrauma Sciences, Simcere, and TRCare. Dr. Cramer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MUSC. Dr. Cramer has stock in Constant Therapeutics, Panaxium, and TRCare. The institution of Dr. Cramer has received research support from NIH; PCORI; Veterans Administration.
Susan T. Iannaccone, MD, FÂ鶹´«Ã½Ó³»­ Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Iannaccone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. The institution of Dr. Iannaccone has received research support from AveXis. The institution of Dr. Iannaccone has received research support from Biogen. The institution of Dr. Iannaccone has received research support from Sarepta. The institution of Dr. Iannaccone has received research support from PTC Therapeutics. The institution of Dr. Iannaccone has received research support from FibroGen. The institution of Dr. Iannaccone has received research support from ReveraGen. The institution of Dr. Iannaccone has received research support from MDA. The institution of Dr. Iannaccone has received research support from PPMD. The institution of Dr. Iannaccone has received research support from NIH. Dr. Iannaccone has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
Gisa Ellrichmann No disclosure on file
Nirav Sanghani, MBBS Dr. Sanghani has nothing to disclose.
Katelyn S. Kavak Ms. Kavak has nothing to disclose.
Aaron Zelikovich, MD Dr. Zelikovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Pablo Bonardo, MD Dr. Bonardo has nothing to disclose.
James Doherty, PhD Dr. Doherty has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Doherty has received stock or an ownership interest from Sage Therapeutics.
Jeremias Motte, MD The institution of Prof. Motte has received research support from Ruhr-Univerity Bochum.
Shivangi Singh, MD Dr. Singh has nothing to disclose.
Natasha Qutab, MD Dr. Qutab has nothing to disclose.
Ebony Jackson-Shaheed No disclosure on file
Mahmoud Dibas, MD Mr. Dibas has nothing to disclose.
Raghav Govindarajan, MD, FÂ鶹´«Ã½Ó³»­ Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Danielle A. Becker, MD Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sk life Science. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus Pharmaceuticals. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis, Inc. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sk Life Science. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz pharmaceuticals. Dr. Becker has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UBC. Dr. Becker has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace. Dr. Becker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus Pharmaceuticals.
Arun Ramamurthy, MD Dr. Ramamurthy has nothing to disclose.
Caila B. Vaughn, PhD No disclosure on file
Claudia A. Munoz, MD, MPH No disclosure on file
Morgan Prust, MD Dr. Prust has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Edelman & Edelman, PC.
Toqa Mahmoud Dahy No disclosure on file
Alaa A. Elshinbary III, Ms Ms. Elshinbary has nothing to disclose.
Jim Wu No disclosure on file
Cuixia Tian, MD Dr. Tian has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Tian has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Tian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Itf. Dr. Tian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenxbio. Dr. Tian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Bioscience. The institution of Dr. Tian has received research support from MDA. The institution of Dr. Tian has received research support from NIH.
Angela M. Hawkins, RN No disclosure on file
Petr Hlustik, MD, PhD The institution of Prof. Hlustik has received research support from Czech Health Research Council (AZV CR).
Amir M. Arain, MD, FÂ鶹´«Ã½Ó³»­ Dr. Arain has nothing to disclose.
Manan Shah, MD, MBBS Dr. Shah has nothing to disclose.
Richard Libman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Libman has nothing to disclose.
Zi-Yue Liu Zi-Yue Liu has nothing to disclose.
Jay D. Varrato, DO Dr. Varrato has nothing to disclose.
Lindsey B. Wooliscroft, MD The institution of Dr. Wooliscroft has received research support from National Institutes of Health.
Niushen Zhang, MD Dr. Zhang has nothing to disclose.
Bo C. Leung, MD Dr. Leung has nothing to disclose.
Jyotika Singh Ms. Singh has nothing to disclose.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Sairah Bashir, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bashir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic .
Justin M. Nolte, MD Dr. Nolte has nothing to disclose.
Justin Abbatemarco, MD Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Abbatemarco has received research support from Amgen.
Anvi Gadani, MD No disclosure on file
Meghan Hubert, MD No disclosure on file
R Arturo Abundes-Corona, MD Dr. Abundes-Corona has nothing to disclose.
Rebekah L. Summers, PhD, PT Rebekah Summers has received personal compensation for serving as an employee of Medtronic. Rebekah Summers has received research support from National Institute of Health.
Oscar Esquivel, MD Mr. Esquivel has nothing to disclose.
Mevish S. Siddiq, MD Dr. Siddiq has nothing to disclose.
Ali Y. Mohamud, MD No disclosure on file
Susana Lopez No disclosure on file
Emmeline Ayers, MPH No disclosure on file
Jaspreet Johal, MD Dr. Johal has nothing to disclose.
Omar Dabbous Omar Dabbous has received personal compensation for serving as an employee of Novartis Gene Therapies. Omar Dabbous has received stock or an ownership interest from Novartis Gene Therapies.
Jeffrey A. Kaye, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Antonio Uccelli, MD An immediate family member of Dr. Uccelli has received personal compensation for serving as an employee of Biogen. The institution of Dr. Uccelli has received research support from Merck. The institution of Dr. Uccelli has received research support from Roche.
Mikael Cohen Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
John W. Day, MD, PhD Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Gene Therapy. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Day has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PepGen. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epirium Bio. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. Day has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Muscular Dystrophy Association. The institution of Dr. Day has received research support from Astellas Pharma. The institution of Dr. Day has received research support from Novartis Gene Therapy. The institution of Dr. Day has received research support from Biogen. The institution of Dr. Day has received research support from Roche/Genentech. The institution of Dr. Day has received research support from Sanofi/Genzyme. The institution of Dr. Day has received research support from Sarepta. The institution of Dr. Day has received research support from Scholar Rock. The institution of Dr. Day has received research support from AMO Pharma. The institution of Dr. Day has received research support from AnnJi. Dr. Day has received research support from CureSMA. The institution of Dr. Day has received research support from Muscular Dystrophy Association. The institution of Dr. Day has received research support from Ionis Pharmaceuticals. The institution of Dr. Day has received research support from NMD Pharma. The institution of Dr. Day has received research support from SMA Foundation. Dr. Day has received intellectual property interests from a discovery or technology relating to health care.
Ildefonso Rodriguez-Leyva, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Columbia.
Elisabetta Capello, MD No disclosure on file
Mohamed Elfil, MBBCh Dr. Elfil has nothing to disclose.
Katelyn Oliveira, DO No disclosure on file
Miguel A. Saucedo, MD Dr. Saucedo has nothing to disclose.
Ohnmar Saw, MD, MBBS No disclosure on file
Gaurav Thakur, DO Dr. Thakur has nothing to disclose.
Mohamed M. Eldokmak, MD Dr. Eldokmak has nothing to disclose.
Tejas R. Mehta, MD Dr. Mehta has nothing to disclose.
Harsh Singh No disclosure on file
Koji Takahashi, PhD Dr. Takahashi has received personal compensation for serving as an employee of Cerevel Therapeutics. Dr. Takahashi has stock in Cerevel Therapeutics.
Shannon M. DiCarlo, MD, FÂ鶹´«Ã½Ó³»­ Dr. DiCarlo has nothing to disclose.
Oscar Martinez, MD No disclosure on file
Mishel Farasatpour, MD No disclosure on file
Yo-El Ju, MD The institution of Dr. Ju has received research support from National Institutes of Health.
Aron S. Buchman, MD No disclosure on file
Daniel Huddleston, MD The institution of Dr. Huddleston has received research support from NIH-NINDS 1K23NS105944-01A1. The institution of Dr. Huddleston has received research support from Michael J. Fox Foundation (MJFF-010556). The institution of Dr. Huddleston has received research support from Lewy Body Dementia Association Research Center of Excellence (Emory). The institution of Dr. Huddleston has received research support from American Parkinson's Disease Association.
Cynthia E. Armand, MD, FÂ鶹´«Ã½Ó³»­ Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CE Interactive. Dr. Armand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Armand has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Armand has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology.
Jan Mares, MD Dr. Mares has nothing to disclose.
Elena Moro, MD, FÂ鶹´«Ã½Ó³»­ Dr. Moro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Moro has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Moro has received research support from Abbott. The institution of Dr. Moro has received research support from Medtronic.
Pavel Hok, MD Dr. Hok has nothing to disclose.
Alissa E. Romano, DO Dr. Romano has nothing to disclose.
Charles D. Schutt, MD Dr. Schutt has nothing to disclose.
Tereza Svrcinova Tereza Svrcinova has nothing to disclose.
Lilly Fagatele Ms. fagatele has nothing to disclose.
Nada A. Hindiyeh, MD Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alder/Lundbeck. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel. Dr. Hindiyeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck .
Jorge J. Pesquera, MD No disclosure on file
Smeer Salam, MD, MBBS No disclosure on file
Klepper Alfredo Garcia, MD Dr. Garcia has nothing to disclose.
Blake Newman, MD Dr. Newman has nothing to disclose.
Erik K. St. Louis, MD The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Elisabeth G. Celius, MD Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Celius has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Celius has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Alberto Albanese, MD Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen pharma. Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz pharms. Dr. Albanese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Publishing Group. Dr. Albanese has a non-compensated relationship as a President with International Association on Parkinsonism and Related Disorders that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Mayela D. Rodriguez Violante, MD Dr. Rodriguez Violante has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rodriguez Violante has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sandoz Novartis. Dr. Rodriguez Violante has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zydus. The institution of Dr. Rodriguez Violante has received research support from LARGE-PD.
Amir Adeli, MD Dr. Adeli has nothing to disclose.
Shitiz K. Sriwastava, MBBS Dr. Sriwastava has nothing to disclose.
Nektaria Alexandri Nektaria Alexandri has received personal compensation for serving as an employee of Merck Healthcare KGaA.
Mauricio José J. Medeiros, MD No disclosure on file
Daniel J. Kaplan, DO No disclosure on file
Feifei Zhai No disclosure on file
Khateeb M. Raza, DO No disclosure on file
Irene Malaty, MD, FÂ鶹´«Ã½Ó³»­ Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Laurent Servais Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Laurent Servais has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. The institution of Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evox. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sysnav. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioHaven. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zentech. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MitoRx. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lupin. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fibrogen. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alltrana. Laurent Servais has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illumina. Laurent Servais has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Laurent Servais has received research support from Roche. The institution of Laurent Servais has received research support from Novartis. The institution of Laurent Servais has received research support from Biogen. The institution of Laurent Servais has received research support from Zentech. The institution of Laurent Servais has received research support from BioHaven. The institution of Laurent Servais has received research support from PerkinHalmers. The institution of Laurent Servais has received research support from Scholar Rock.
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Francesco Muntoni, MD Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
Aliya Sarwar, MD Dr. Sarwar has received personal compensation in the range of $500-$4,999 for serving as a Amneal Fellowship Director Advisory Board Member with Amneal -Rytary.
Melissa Motta, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Motta has nothing to disclose.
Hera A. Kamdar, MD Dr. Kamdar has nothing to disclose.
Andrea J. Arreguin No disclosure on file
Marika Antimisiaris, MD Dr. Antimisiaris has nothing to disclose.
Amira A. Aboali, MD Dr. Aboali has nothing to disclose.
Chelsea C. Yager, PA No disclosure on file
Myint T. Naing, FRCP, DrMedSc No disclosure on file
Aaron M. Carlson, MD Dr. Carlson has received research support from Horizon Therapeutics (Amgen).
Marcela Uribe Roca The institution of Marcela Uribe Roca has received research support from Roche.
Martha Robinson, MD Dr. Robinson has nothing to disclose.
Olga Gomez Siegert, MD Dr. Gomez Siegert has nothing to disclose.
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Julie A. Fields, PhD The institution of Dr. Fields has received research support from National Institutes of Health. The institution of Dr. Fields has received research support from Patient-Centered Outcomes Research Institute.
Robert H. Fryer, MD, PhD No disclosure on file
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Roland G. Henry, PhD Dr. Henry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MEDDAY. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Henry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Henry has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi/Genzyme.
Farhan Siddiq, MD Dr. Siddiq has nothing to disclose.
Anand V. Patel, MD Dr. Patel has nothing to disclose.
Itay Lotan, MD Dr. Lotan has nothing to disclose.
Robert W. Charlson, MD Dr. Charlson has nothing to disclose.
Lixin Zhou Lixin Zhou has nothing to disclose.
Dilip Singh, MD, MBBS Dr. Singh has nothing to disclose.
Salman Assad, MD, MBBS Dr. Assad has nothing to disclose.
Thomas A. Nelson, MD Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adya.
Samrina Hanif, MD Dr. Hanif has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova .
Marie Vidailhet, MD, PhD No disclosure on file
Sven Schippling No disclosure on file
Alejandro R. Marfil-Rivera, MD Dr. Marfil-Rivera has nothing to disclose.
Shahmir Sohail No disclosure on file
Valerie A. Block, DPTSc Dr. Block has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Block has received research support from National MS Society.
Thomas Berk, MD Dr. Berk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impex Neuropharma. Dr. Berk has received publishing royalties from a publication relating to health care. Dr. Berk has received publishing royalties from a publication relating to health care.
Amber M. Alexander Amber M. Alexander has nothing to disclose.
Yun Fang No disclosure on file
Rebecca Wu, MD No disclosure on file
Ian Cossentino, BS No disclosure on file
Grace Clark No disclosure on file
Mei-jun Shu Mei-jun Shu has nothing to disclose.
Rosangel E. Cruz, MA Ms. Cruz has nothing to disclose.
Jennifer S. McLeland Ms. McLeland has nothing to disclose.
Marie-Eve Gendron Marie-Eve Gendron has received personal compensation for serving as an employee of Merz Therapeutics.
Badria Munir, MD Dr. Munir has nothing to disclose.
Benedetta Nacmias Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Fred Anderson, PhD Dr. Anderson has nothing to disclose.
Michelle Kaku, MD Dr. Kaku has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Fatcliffe Harten Galamaga LLP.
Matthew N. Jaffa, DO Dr. Jaffa has nothing to disclose.
Ehtesham Khalid, MBBS Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Khalid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Khalid has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Annie L. Hsieh, MD, PhD An immediate family member of Dr. Hsieh has received personal compensation for serving as an employee of Pfizer.
Giacomo Boffa Mr. Boffa has nothing to disclose.
Alice Laroni Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alice Laroni has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alice Laroni has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alice Laroni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Alice Laroni has received research support from Fondazione Italiana Sclerosi MUltipla . The institution of Alice Laroni has received research support from Ministero Salute. The institution of Alice Laroni has received research support from Ministero UNiversità.
Mariana Espinosa-Polanco No disclosure on file
Amy E. Bullock, PhD Dr. Bullock has received personal compensation for serving as an employee of Sage Therapeutics, Inc. . Dr. Bullock has stock in Sage Therapeutics, Inc.
Lisa Belter Lisa Belter has received personal compensation for serving as an employee of Cure SMA.
Sushant Puri, MBBS Dr. Puri has nothing to disclose.
Cesar E. Escamilla-Ocanas, MD Dr. Escamilla-Ocanas has nothing to disclose.
Coleton Towles No disclosure on file
David Dai No disclosure on file
Steven C. Yang, DO Dr. Yang has nothing to disclose.
Jun Ni Jun Ni has nothing to disclose.
Amelie Pelletier Ms. Pelletier has nothing to disclose.
Denis Vezina, PhD No disclosure on file
Elizabeth Silbermann, MD Dr. Silbermann has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Silbermann has received research support from VA.
Nicholas Tost No disclosure on file
Maxim Mokin, MD, PhD Dr. Mokin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Mokin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Mokin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Mokin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Mokin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Foley Mansfield.
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Jeffrey A. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Joe Verghese, MD, FÂ鶹´«Ã½Ó³»­ Dr. Verghese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms Inc. The institution of Dr. Verghese has received research support from National Institutes of Health.
Mary R. Rensel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for genentech. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Roche- Genentech . The institution of Dr. Rensel has received research support from Biogen.
Hussam A. Yacoub, DO Dr. Yacoub has nothing to disclose.
Amber Salter, PhD Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
James F. Paskavitz, MD No disclosure on file
Kavita Nair, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PhRMA Foundation. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MJH Lifesciences. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Anylam . Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Patient Experience. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Esai. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MHJ Life Sciences. Dr. Nair has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Nair has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for ICER. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from Genentech. The institution of Dr. Nair has received research support from Phrma Foundation. The institution of Dr. Nair has received research support from Bristol Meyers Squibb. The institution of Dr. Nair has received research support from Novartis. The institution of Dr. Nair has received research support from NINDS. The institution of Dr. Nair has received research support from Sanofi Genzyme. The institution of Dr. Nair has received research support from Kyverna Therapeutcis. Dr. Nair has a non-compensated relationship as a Board Member with Center for Improving Value in Healthcare that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Robert J. Fox, MD, FÂ鶹´«Ã½Ó³»­ Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Machteld E. Hillen, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Hillen has received research support from Genentech.
Amar Dhand, MD, DPhil Dr. Dhand has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ECHAS, LLC. Dr. Dhand has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ultress Quinn. The institution of Dr. Dhand has received research support from NIH. Dr. Dhand has received intellectual property interests from a discovery or technology relating to health care.
Tirisham Gyang, MD Dr. Gyang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono.
Stefan Sillau Stefan Sillau has nothing to disclose.
Jessica Frey, MD The institution of Dr. Frey has received research support from Tourette Association of America.
Nada Ahmed, MD Dr. Ahmed has nothing to disclose.
Gregory Owens, PhD Dr. Owens has received intellectual property interests from a discovery or technology relating to health care.
Atif Zafar, MD Dr. Zafar has nothing to disclose.
Tapan Mehta, MD Dr. Mehta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Balt, Medtronic, J&J, Terumo.
Gabriel D. Pinilla Monsalve, MD, MSc Dr. Pinilla Monsalve has nothing to disclose.
Mangala Gopal, MD Dr. Gopal has nothing to disclose.
Gary R. Cutter, PhD Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Hamada H. Altalib, DO The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
Liliana A. Ramirez-Gomez, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Ramirez-Gomez has received research support from NIA-NIH.
Bjorn Ambrosius No disclosure on file
Mohamed Fahmy Doheim Mr. Doheim has nothing to disclose.
Preethy Pankaj, MBBS Dr. Pankaj has nothing to disclose.
larry rubin No disclosure on file
Maria V. Diaz Rojas, MD Dr. Diaz Rojas has nothing to disclose.
Fariha Jamal No disclosure on file
Amy Durand, MD No disclosure on file
Alexandra S. Reynolds, MD Dr. Reynolds has nothing to disclose.
Shannon Y. Chiu, MD, MSc Dr. Chiu has received research support from NIH.
Shehryar Sheikh No disclosure on file
Kenneth Carazo No disclosure on file
Nikhil M. Patel, MD, MBA No disclosure on file
Nicholas Thompson The institution of Nicholas Thompson has received research support from EMD Serono.
Nicholas A. Morris, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Morris has received research support from Â鶹´«Ã½Ó³»­. The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Webinar Speaker with Kreg Therapeutics. Dr. Morris has a non-compensated relationship as a Editorial Board Member with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Morris has a non-compensated relationship as a Editorial Board Member with Neurocritical Care Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Renato Arruda, MD No disclosure on file
Perry Shieh, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Shieh has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biogen. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Shieh has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Shieh has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
Timothy K. Vartanian, MD, PhD Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Vartanian has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Vartanian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tisch MS Center. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Gishlaine Alfonso, MD, FÂ鶹´«Ã½Ó³»­ Dr. Alfonso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion .
George R. Jackson, MD, PhD Dr. Jackson has nothing to disclose.
Ethan Hoffman No disclosure on file
Daniel Krashin, MD Dr. Krashin has nothing to disclose.
Benoit Kullmann, MD No disclosure on file
Hamza Coban, MD Dr. Coban has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono.
Charisse D. Litchman, MD Dr. Litchman has received personal compensation for serving as an employee of BeCare . Dr. Litchman has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nurx. Dr. Litchman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan.
Erin R. Fiedler, DO Dr. Fiedler has nothing to disclose.
Caterina Lapucci, MD Dr. Lapucci has nothing to disclose.
Nestor Beltre, MD Dr. Beltre has nothing to disclose.
Marcus Droege No disclosure on file
Heloise Joly No disclosure on file
Alexis A. Clay, MD No disclosure on file
Melissa Huynh Mabry, MD Dr. Huynh Mabry has nothing to disclose.
Rashid Kazerooni Rashid Kazerooni has received personal compensation for serving as an employee of Merz Therapeutics.
Osman Ozel, MD Dr. Ozel has nothing to disclose.
Rafael M. Klimas Mr. Klimas has nothing to disclose.
Thara Bala, MD Dr. Bala has nothing to disclose.
Tess E. Cersonsky Ms. Cersonsky has nothing to disclose.
Joshua Kramer, MD Dr. Kramer has nothing to disclose.
James B. Lewin, PharmD Dr. Lewin has received personal compensation for serving as an employee of Biogen. Dr. Lewin has stock in Biogen.
Yakeel Quiroz, PhD Dr. Quiroz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Quiroz has received research support from National Institutes of Health. The institution of Dr. Quiroz has received research support from Alzheimer's Association. The institution of Dr. Quiroz has received research support from Mass General Hospital Executive Committee on Research (ECOR). Dr. Quiroz has received intellectual property interests from a discovery or technology relating to health care.
Bryan M. Gough, MD No disclosure on file
Courtney Knapp No disclosure on file
Evan Popoff No disclosure on file
Dania Qaryouti, MD Dr. Qaryouti has nothing to disclose.
Augusto A. Miravalle, MD, FÂ鶹´«Ã½Ó³»­ Dr. Miravalle has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Miravalle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG therapeutics. Dr. Miravalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Miravalle has received research support from Genzyme. The institution of Dr. Miravalle has received research support from EMD Serono. The institution of Dr. Miravalle has received research support from Alexion.
Jasem Y. Al-Hashel, MD Dr. Al-Hashel has nothing to disclose.
Savary Om No disclosure on file
Steve Kanes, MD, PhD Dr. Kanes has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Kanes has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Verge Genomics. Dr. Kanes has received intellectual property interests from a discovery or technology relating to health care.
Irene R. Patniyot, MD No disclosure on file
Jacob Didion, MD No disclosure on file
Katherine Werbaneth, MD Dr. Werbaneth has nothing to disclose.
Nancy Santilli, RN, PNP, MN No disclosure on file
Nwe Nwe Win, MBBS, MRCP No disclosure on file
Licinio M. Craveiro, MD, PhD Dr. Craveiro has received personal compensation for serving as an employee of Hoffmann La-Roche. Dr. Craveiro has received stock or an ownership interest from Hoffmann La-Roche.
Panayiota Trifillis Panayiota Trifillis has received personal compensation for serving as an employee of PTC Therapeutics. Panayiota Trifillis has received stock or an ownership interest from PTC Therapeutics, Inc.. Panayiota Trifillis has received intellectual property interests from a discovery or technology relating to health care.
Ilya Kister, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Brenda L. Wong, MD No disclosure on file
Jeffrey M. Katz, MD Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Katz Medical Consulting. The institution of Dr. Katz has received research support from Medtronic.
Oana M. Dumitrascu, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dumitrascu has nothing to disclose.
Joseph M. Palumbo, MD Dr. Palumbo has received personal compensation for serving as an employee of BioVie. An immediate family member of Dr. Palumbo has received personal compensation for serving as an employee of Merck Research Laboratories. Dr. Palumbo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stalicla SA. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Psychae Therapeutics Pty Ltd. Dr. Palumbo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Phocus Pharmaceuticals Inc.. Dr. Palumbo has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for BioVie. Dr. Palumbo has or had stock in BioVie. An immediate family member of Dr. Palumbo has or had stock in Merck Research Laboratories. The institution of Dr. Palumbo has received research support from United States Department of Defense. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care. Dr. Palumbo has received intellectual property interests from a discovery or technology relating to health care.
Lik Hang Tommy Chan, MD No disclosure on file
Neha Patel, MD No disclosure on file
Ming Yao Ming Yao has nothing to disclose.
Ashmanie Mahatoo, MD No disclosure on file
Nicholas Cothros, MD No disclosure on file
Alex J. Medina Escobar, MD No disclosure on file
Robert P. Lisak, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Juan F. Gongora Rivera, MD, MD, MSc, PhD Dr. Gongora Rivera has nothing to disclose.
Adam Kirton, MD Dr. Kirton has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Multiple. The institution of Dr. Kirton has received research support from Multiple.
Amelia K. Boehme, PhD Dr. Boehme has nothing to disclose.
Frederic Sedel No disclosure on file
Susan Matesanz, MD Dr. Matesanz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Matesanz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Matesanz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atamyo . The institution of Dr. Matesanz has received research support from Sarepta . The institution of Dr. Matesanz has received research support from Pfizer. The institution of Dr. Matesanz has received research support from Genentech/Roche.
Keithan Sivakumar, MD Dr. Sivakumar has nothing to disclose.
Ana Verdecia, MD No disclosure on file
Sachin A. Kothari, MD Dr. Kothari has nothing to disclose.
Ian Carroll No disclosure on file
Hilda V. Gutierrez, MD Ms. Gutierrez has nothing to disclose.
Cecilia Peterson An immediate family member of Ms. Peterson has received personal compensation for serving as an employee of 100Plus.
Cynthia G. Sarabia-tapia, MD No disclosure on file
Yazmin Rios-Solis No disclosure on file
Rebecca T. Hsu, MD Dr. Hsu has nothing to disclose.
Benjamin Lin No disclosure on file
Akashleena Mallick, MD, MBBS Dr. Mallick has nothing to disclose.
Sneh Preet Munder, MD Dr. Munder has nothing to disclose.
Sandro Sorbi Sandro Sorbi has nothing to disclose.
Manoj Malhotra, MD Dr. Malhotra has received personal compensation for serving as an employee of Eisai.
Jonathan Dissin, MD Dr. Dissin has received stock or an ownership interest from GlaxoSmithKline. Dr. Dissin has received stock or an ownership interest from Abbvie.
Michael Dobbs, MD Dr. Dobbs has received publishing royalties from a publication relating to health care.
Ashley Jones No disclosure on file
Leonardo Almeida No disclosure on file
Kaitlin Reilly-Kit, MD Dr. Reilly-Kit has nothing to disclose.
Gabriel Torrealba Acosta, MD Dr. Torrealba Acosta has nothing to disclose.
Stephanie L. Bissonnette, DO The institution of Dr. Bissonnette has received research support from SAGE Therapeutics. The institution of Dr. Bissonnette has received research support from Huntington's Disease Society of America. The institution of Dr. Bissonnette has received research support from CHDI Foundation.
Kayoko Saito No disclosure on file
Thomas Ford, MD Dr. Ford has nothing to disclose.
Maria Cellerino, MD Maria Cellerino has nothing to disclose.
Arman Cakar Arman Cakar has nothing to disclose.
Tahir H. Obeid, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Chintan Shah, MD No disclosure on file
Nicolo Bruschi Mr. Bruschi has nothing to disclose.
Salvatore Mazzeo Mr. Mazzeo has nothing to disclose.
Arshom Foroutan No disclosure on file
Elysia James, MD Dr. James has nothing to disclose.
Alessandro Serra, MD Dr. Serra has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Serra has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb.
Mehdi Ghasemi, MD Dr. Ghasemi has nothing to disclose.
Sarah Camargos, MD No disclosure on file
Jiangyong Min, MD Dr. Min has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic . Dr. Min has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for CredentialMed, LLC. The institution of Dr. Min has received research support from Corerwell Health Foundation .
Tania Kuempfel, MD Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon.
Gioacchino Tedeschi, MD Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Hongyan Li, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Li has nothing to disclose.
Thalia S. Field, MD Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Field has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Field has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Canadian Medical Protective Association, plaintiff. The institution of Dr. Field has received research support from Vancouver Coastal Health Research Institute, Heart and Stroke Foundation of Canada, Brain Canada and CIHR. Dr. Field has a non-compensated relationship as a Editorial board with Stroke that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Field has a non-compensated relationship as a Editorial board with CJNS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Field has a non-compensated relationship as a Editorial board with JNNP that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Field has a non-compensated relationship as a Board member with DESTINE Health that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Field has a non-compensated relationship as a Board Member with Vancouver General Hospital Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Muhib Khan, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Khan has received research support from Mayo Clinic Â鶹´«Ã½Ó³»­ Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
Melih Tutuncu, MD No disclosure on file
Farren Briggs, PhD The institution of Prof. Briggs has received research support from NIH.
H. E. Hinson, MD, MCR, FÂ鶹´«Ã½Ó³»­ Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Mandip S. Dhamoon, MD, MPH Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
Paolo Ragonese No disclosure on file
Carlos A. Pardo-Villamizar, MD The institution of Dr. Pardo-Villamizar has received research support from National Institutes of Health. The institution of Dr. Pardo-Villamizar has received research support from Bart McLean Fund for Neuroimmunology Research .
Marinella Clerico, MD Dr. Clerico has nothing to disclose.
Noah Rosen, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rosen has received personal compensation for serving as an employee of Northwell Health. An immediate family member of Dr. Rosen has received personal compensation for serving as an employee of New York University. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer . Dr. Rosen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Rosen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan/ Abbvie. Dr. Rosen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer. Dr. Rosen has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
Teerin Liewluck, MD, FÂ鶹´«Ã½Ó³»­ Dr. Liewluck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. Liewluck has received publishing royalties from a publication relating to health care.
Markus Krumbholz Markus Krumbholz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme, Merck, Novartis, Roche. The institution of Markus Krumbholz has received research support from Merck.
Vicki A. Ramsey-Williams, MD, PhD Dr. Ramsey-Williams has nothing to disclose.
Ruth Andrea Salazar Camelo, MD Dr. Salazar Camelo has nothing to disclose.
Christopher Wilkins, MD No disclosure on file
Xiao-Tang Kong, MD, PhD Dr. Kong has nothing to disclose.
Elisabetta Signoriello Elisabetta Signoriello has nothing to disclose.
Melissa Schorn, ARNP, DNP No disclosure on file
Elif Everest, PhD Ms. Everest has received personal compensation in the range of $50,000-$99,999 for serving as a postdoctoral visiting fellow with National Institutes of Health.
Jose Danilo B. Diestro, MD Dr. Diestro has nothing to disclose.
Nabil Wees, MD Dr. Wees has nothing to disclose.
William Ueng, MD Dr. Ueng has nothing to disclose.
Satheesh Kumar Bokka, MD No disclosure on file
Tehniyat Baig, MD Ms. Baig has nothing to disclose.
Jeffrey Lambe, MD Dr. Lambe has nothing to disclose.
Rahul V. Sonone, MD No disclosure on file
Grant T. Corbett, PhD Dr. Corbett has received personal compensation for serving as an employee of Novo Nordisk Inc.. Dr. Corbett has stock in Novo Nordisk Inc.
Maria Sarfraz, MBBS Dr. Sarfraz has nothing to disclose.
Roberta Lanzillo Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Thomas W. Smith, MD No disclosure on file
Gianmarco Abbadessa, MD Dr. Abbadessa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Joy R. Esterlitz No disclosure on file
Kerri S. Remmel, MD, PhD Dr. Remmel has nothing to disclose.
Michael Haboubi, DO Dr. Haboubi has nothing to disclose.
Basil T. Darras, MD The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Ugur Uygunoglu Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey.
Andrew Treister, MD Dr. Treister has nothing to disclose.
Katelyn E. Gay Ms. Gay has received personal compensation for serving as an employee of The Emmes Company, LLC.
Romergryko G. Geocadin, MD, FÂ鶹´«Ã½Ó³»­ Dr. Geocadin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Consulting.
Faisal A. Alsallom, MD Dr. Alsallom has nothing to disclose.
Alain Z. Lekoubou Looti, MD Dr. Lekoubou Looti has nothing to disclose.
Sophia Woodson No disclosure on file
Yingmai Yang No disclosure on file
Marc-Olivier Deguise No disclosure on file
Rahul D. Abhyankar, MD No disclosure on file
Naga Krishnakanth Madireddy, MD Dr. Madireddy has nothing to disclose.
Pritikanta Paul, MD The institution of Dr. Paul has received research support from ZS Associates.
Renata Scalco, MD No disclosure on file
Nicole Joseph No disclosure on file
Kina Zhou No disclosure on file
Julien F. Bally, MD No disclosure on file
Younes Adam Tabi No disclosure on file
Parul Agarwal Parul Agarwal has nothing to disclose.
Xinhua Wan No disclosure on file
Ingo Kleiter Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Ingo Kleiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall.
Ramiro G. Castro Apolo, MD Dr. Castro Apolo has nothing to disclose.
Mia T. Minen, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Ajaz Sheikh, MD Dr. Sheikh has nothing to disclose.
Joseph Zachariah, DO Dr. Zachariah has nothing to disclose.
Imran I. Ali, MD, FÂ鶹´«Ã½Ó³»­ Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
William D. Gaillard, MD The institution of Dr. Gaillard has received research support from all federal or foundation grants, NINDS, NIDCD, NICHD, NSF ,PERF.
Margherita Milone, MD, FÂ鶹´«Ã½Ó³»­ Dr. Milone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian Therapeutics. Dr. Milone has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics, Â鶹´«Ã½Ó³»­. The institution of Dr. Milone has received research support from Mayo Clinic, CCaTS-CBD. The institution of Dr. Milone has received research support from Mayo Clinic, SGP Award. The institution of Dr. Milone has received research support from MDA for Care Center grant. The institution of Dr. Milone has received research support from Regenerative medicine Minnesota.
Masud Husain, MD, FÂ鶹´«Ã½Ó³»­ Dr. Husain has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Husain has stock in NeuHealth. The institution of Dr. Husain has received research support from Wellcome Trust. Dr. Husain has received publishing royalties from a publication relating to health care.
Naveed Akhtar, MD, FÂ鶹´«Ã½Ó³»­ Dr. Akhtar has nothing to disclose.
Churl-Su Kwon, MBBS Dr. Kwon has nothing to disclose.
Ulf Ziemann, MD No disclosure on file
Naeem Mahfooz, MD Dr. Mahfooz has nothing to disclose.
Benjamin W. Friedman, MD, MS Benjamin W. Friedman, MD, MS has nothing to disclose.
Wei Liu, MD Dr. Liu has nothing to disclose.
Giacomo Lus Giacomo Lus has nothing to disclose.
Sajish Jacob, MBBS No disclosure on file
Hesham A. Abboud, MD Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. The institution of Dr. Abboud has received research support from UCB. Dr. Abboud has received publishing royalties from a publication relating to health care.
Sabahattin Saip Sabahattin Saip has nothing to disclose.
Yohannes W. Woldeamanuel, MD Dr. Woldeamanuel has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum. Dr. Woldeamanuel has received personal compensation in the range of $0-$499 for serving as a Consultant for Research Square. The institution of Dr. Woldeamanuel has received research support from NINDS. Dr. Woldeamanuel has a non-compensated relationship as a Chief Medical Officer, Co-Founder with Ex-Amplify Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Woldeamanuel has a non-compensated relationship as a Adjunct Faculty with Arizona State University that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Woldeamanuel has a non-compensated relationship as a Founder & Consultant with Advanced Clinical & Research Center that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Adam Book, MD No disclosure on file
Peter A. Calabresi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Nathalie Jette, MD, MSc, FRCPC, FÂ鶹´«Ã½Ó³»­ Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Florian Eichler, MD An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atlas Venture. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leal Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orchard Tx. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Therapeutics. The institution of Dr. Eichler has received research support from ASPA Therapeutics. The institution of Dr. Eichler has received research support from Abbvie. The institution of Dr. Eichler has received research support from Ionis Pharmaceuticals.
Anum H. Riaz, MD Dr. Riaz has nothing to disclose.
Sabrina Esposito No disclosure on file
Micaela R. Owens, DO Dr. Owens has nothing to disclose.
Pietro Iaffaldano No disclosure on file
Shiv Saidha, MD Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Setpoint Medical. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReWind Therapeutics. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Pharmaceuticals. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Saidha has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal ETC. Dr. Saidha has stock in June Brain. Dr. Saidha has stock in Lapix Therapeutics. The institution of Dr. Saidha has received research support from Biogen. The institution of Dr. Saidha has received research support from Genentech. The institution of Dr. Saidha has received research support from Novartis. The institution of Dr. Saidha has received research support from Lapix Therapeutics. The institution of Dr. Saidha has received research support from Novartis.
Jacqueline French, MD, FÂ鶹´«Ã½Ó³»­ Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Anthony E. Lang, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Nizar Souayah, MD, FÂ鶹´«Ã½Ó³»­ Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Simona Bonavita No disclosure on file
Christopher D. Stephen, MB ChB, FRCP, MSc, SM The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Uwe Zettl Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Uwe Zettl has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Uwe Zettl has received research support from BMBF(Government).
Tracy Ander, DO No disclosure on file
Martin Kerschensteiner, MD No disclosure on file
Jignesh J. Shah, MD No disclosure on file
Mihai C. Sandulescu, MD Dr. Sandulescu has nothing to disclose.
Saurav Das, MD Dr. Das has nothing to disclose.
Shanglin Li, MD No disclosure on file
Markus Kowarik Markus Kowarik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck, Roche, Celgene, Sanofi-Genzyme, Novartis and Biogen. The institution of Markus Kowarik has received research support from Merck. The institution of Markus Kowarik has received research support from Sanofi Genzyme.
Joseph Seemiller, MD Dr. Seemiller has nothing to disclose.
Wajiha Yousuf, MD Dr. Yousuf has nothing to disclose.
Mika Martikainen No disclosure on file
Cristina Schreckinger, MD No disclosure on file
Angeliki Filippatou, MD Dr. Filippatou has nothing to disclose.
Joachim Havla, MD Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Havla has received research support from Merck.
Giovanna Borriello Giovanna Borriello has nothing to disclose.
Luigi Lavorgna Luigi Lavorgna has nothing to disclose.
Nadeem I. Khan, MD Dr. Khan has nothing to disclose.
Jee-young Han, MD Dr. Han has nothing to disclose.
Olwen Murphy, MD Dr. Murphy has nothing to disclose.
Eda Turanli The institution of Eda Turanli has received research support from Scientific and Technological Research Council of Turkey (TÜBITAK). The institution of Eda Turanli has received research support from Turkish MS Society. The institution of Eda Turanli has received research support from Acibadem University Scientific Research Projects Commission . The institution of Eda Turanli has received research support from Istanbul University Scientific Research Projects Commission .
Muniza Sheikh Ms. Sheikh has received personal compensation for serving as an employee of The Emmes Company.
Clare Angeli G. Enriquez, MD No disclosure on file
Lauren R. Moore No disclosure on file
Weston Daniel No disclosure on file
Maya Hrachova, DO Dr. Hrachova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Therapeutics.
Kathryn Hagen, MD No disclosure on file
George R. Hanna, MD No disclosure on file
Paul V. Motika, MD Dr. Motika has nothing to disclose.
Melanie Leigh D. Supnet, MD No disclosure on file
Alper Bulbul Alper Bulbul has nothing to disclose.
Etienne REGULIER No disclosure on file
Sidra Saleem, MD Dr. Saleem has nothing to disclose.
Tyler Crissinger, MD Dr. Crissinger has nothing to disclose.